Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients
- 19 December 2023
- journal article
- research article
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 25 (3) , 555-573
Abstract
Hypopituitarism, or the failure to secrete hormones produced by the anterior pituitary (adenohypophysis) and/or to release hormones from the posterior pituitary (neurohypophysis), can be congenital or acquired. When more than one pituitary hormone axis is impaired, the condition is known as combined pituitary hormone deficiency (CPHD). The deficiency may be primarily due to a hypothalamic or to a pituitary disorder, or concomitantly both, and has a negative impact on target organ function. This review focuses on the pathophysiology, diagnosis and management of anterior pituitary hormone deficiency in the pediatric age. Congenital hypopituitarism is generally due to genetic disorders and requires early medical attention. Exposure to toxicants or intrauterine infections should also be considered as potential etiologies. The molecular mechanisms underlying the fetal development of the hypothalamus and the pituitary are well characterized, and variants in the genes involved therein may explain the pathophysiology of congenital hypopituitarism: mutations in the genes expressed in the earliest stages are usually associated with syndromic forms whereas variants in genes involved in later stages of pituitary development result in non-syndromic forms with more specific hormone deficiencies. Tumors or lesions of the (peri)sellar region, cranial radiation therapy, traumatic brain injury and, more rarely, other inflammatory or infectious lesions represent the etiologies of acquired hypopituitarism. Hormone replacement is the general strategy, with critical periods of postnatal life requiring specific attention.Keywords
This publication has 156 references indexed in Scilit:
- Fetal thyroïdologyBest Practice & Research Clinical Endocrinology & Metabolism, 2014
- On the Benefits and Risks of Proton Therapy in Pediatric CraniopharyngiomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Candidate genes for panhypopituitarism identified by gene expression profilingPhysiological Genomics, 2011
- Hypogonadotropic hypogonadism in subjects with DAX1 mutationsMolecular and Cellular Endocrinology, 2011
- GATA2 Mediates Thyrotropin-Releasing Hormone-Induced Transcriptional Activation of the Thyrotropin β GenePLOS ONE, 2011
- Unexpected Endocrine Features and Normal Pigmentation in a Young Adult Patient Carrying a Novel Homozygous Mutation in the POMC GeneThe Journal of Clinical Endocrinology & Metabolism, 2008
- Homeodomain-Mediated β-Catenin-Dependent Switching Events Dictate Cell-Lineage DeterminationCell, 2006
- Geographical Distribution of Optic Nerve Hypoplasia and Septo-optic Dysplasia in Northwest EnglandThe Journal of Pediatrics, 2006
- Maternal-Fetal Transfer of Thyroxine in Congenital Hypothyroidism Due to a Total Organification Defect or Thyroid AgenesisNew England Journal of Medicine, 1989
- Origin of luteinizing hormone-releasing hormone neuronsNature, 1989